SCHEMBL6984646

SCHEMBL6984646

Nc1nc(N)nc(-c2ccc(Cl)nc2)n1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.59
NPC1 O15118 5/20 0.59
PIK3CD O00329 1/20 0.57
POLB P06746 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA2B P29275 1/20 0.47
ADORA1 P30542 1/20 0.47
DHFR P00374 2/20 0.45
CYP2A6 P11509 1/20 0.44
CASP3 P42574 1/20 0.42
NOTUM Q6P988 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HTR2B P41595 1/20 0.39
PDE4D Q08499 1/20 0.39
PIK3CA P42336 1/20 0.39
NAPRT Q6XQN6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14214695 0.83 PIK3CD (0.52) RAB9ANPC1PIK3CDADORA3DHFR
SCHEMBL8153199 0.81 MAPK1 (0.47) RAB9ANPC1POLBDHFRKDM4E
SCHEMBL16905411 0.79 PIK3CD (0.50) RAB9ANPC1PIK3CDCYP2A6CASP3
SCHEMBL6982063 0.76 RAB9A (0.48) RAB9ANPC1PIK3CDPOLBADORA3
SCHEMBL21677813 0.76 NPC1 (0.56) RAB9ANPC1PIK3CDPOLBADORA3
SCHEMBL8329922 0.76 HSP90AA1 (0.61) PIK3CDADORA2AADORA1CYP2A6KDM4E
SCHEMBL1662273 0.75 PIK3CD (0.73) RAB9ANPC1PIK3CDPOLBCYP2A6
SCHEMBL28880529 0.75 RAB9A (0.76) RAB9ANPC1POLBADORA3ADORA2A
SCHEMBL18770664 0.74 NPC1 (0.54) RAB9ANPC1PIK3CDPOLBADORA3
SCHEMBL672681 0.74 NPC1 (1.00) RAB9ANPC1POLBADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed